| Sep 29, 2025 |
Oct 1, 2025 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
25.0
|
-3,250
|
-12.38%
|
✓
|
$66.3K |
| Aug 27, 2025 |
Aug 29, 2025 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
25.0
|
-3,250
|
-12.38%
|
✓
|
$67K |
| Jul 28, 2025 |
Jul 30, 2025 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
25.0
|
-3,250
|
-12.38%
|
✓
|
$66.5K |
| Jul 10, 2025 |
Jul 14, 2025 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
41.3
|
-1,000
|
-4.17%
|
✓
|
$22.7K |
| Jun 27, 2025 |
Jul 1, 2025 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
25.0
|
-3,250
|
-12.38%
|
✓
|
$68K |
| Jun 13, 2025 |
Jun 17, 2025 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
25.0
|
-3,000
|
-11.54%
|
✓
|
$67.7K |
| May 27, 2025 |
May 29, 2025 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
25.0
|
-3,250
|
-12.38%
|
✓
|
$52.6K |
| Apr 28, 2025 |
Apr 30, 2025 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
25.0
|
-3,250
|
-12.38%
|
✓
|
$60.7K |
| Mar 27, 2025 |
Mar 31, 2025 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
25.0
|
-3,250
|
-12.38%
|
✓
|
$69.3K |
| Mar 24, 2025 |
Mar 26, 2025 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
41.3
|
-1,000
|
-4.17%
|
✓
|
$22.5K |
| Feb 27, 2025 |
Mar 3, 2025 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
20.0
|
-3,250
|
-20.00%
|
✓
|
$66.3K |
| Feb 5, 2025 |
Feb 7, 2025 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
36.3
|
-1,000
|
-7.14%
|
✓
|
$22.5K |
| Jan 27, 2025 |
Jan 29, 2025 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
20.0
|
-3,250
|
-20.00%
|
✓
|
$70.2K |
| Dec 13, 2024 |
Jan 7, 2025 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
36.3
|
-1,000
|
-7.14%
|
✓
|
$25K |
| Dec 27, 2024 |
Dec 31, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
10.0
|
-4,250
|
-100.00%
|
✓
|
$94.5K |
| Nov 27, 2024 |
Dec 2, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
10.0
|
-5,250
|
-100.00%
|
✓
|
$130.7K |
| Oct 28, 2024 |
Oct 30, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
10.0
|
-6,250
|
-100.00%
|
✓
|
$178.5K |
| Oct 18, 2024 |
Oct 22, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
13.8
|
-814
|
-100.00%
|
✓
|
$24.4K |
| Oct 4, 2024 |
Oct 8, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
7.5
|
-11,488
|
-100.00%
|
✓
|
$316K |
| Oct 1, 2024 |
Oct 3, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
13.8
|
-521
|
-100.00%
|
✓
|
$14.3K |
| Sep 27, 2024 |
Oct 1, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
10.0
|
-6,250
|
-100.00%
|
✓
|
$153.8K |
| Aug 27, 2024 |
Aug 29, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
10.0
|
-4,250
|
-100.00%
|
✓
|
$95.8K |
| Jul 31, 2024 |
Aug 2, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
13.8
|
-991
|
-100.00%
|
✓
|
$27.3K |
| Jul 29, 2024 |
Jul 31, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
10.0
|
-5,250
|
-100.00%
|
✓
|
$140.1K |
| Jul 12, 2024 |
Jul 16, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
10.0
|
-3,000
|
-100.00%
|
✓
|
$75.2K |
| Jun 27, 2024 |
Jul 1, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
10.0
|
-4,250
|
-100.00%
|
✓
|
$95.9K |
| May 28, 2024 |
May 30, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
10.0
|
-4,250
|
-100.00%
|
✓
|
$98.5K |
| May 3, 2024 |
May 7, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
13.8
|
-1,000
|
-100.00%
|
✓
|
$22.5K |
| Apr 29, 2024 |
May 1, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
10.0
|
-3,250
|
-100.00%
|
✓
|
$55.2K |
| Apr 11, 2024 |
Apr 15, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
7.5
|
-14,000
|
-100.00%
|
✓
|
$346.1K |
| Mar 27, 2024 |
Mar 29, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
10.0
|
-3,250
|
-100.00%
|
✓
|
$59.3K |
| Feb 27, 2024 |
Feb 29, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
10.0
|
-3,250
|
-100.00%
|
✓
|
$55.2K |
| Jan 29, 2024 |
Jan 31, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
10.0
|
-3,250
|
-100.00%
|
✓
|
$51.4K |
| Dec 28, 2023 |
Jan 2, 2024 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
10.0
|
-11,870
|
-100.00%
|
✓
|
$178.3K |
| Dec 22, 2023 |
Dec 27, 2023 |
Enliven Therapeutics, Inc.
|
CFO |
Sell |
13.8
|
-1,130
|
-100.00%
|
✓
|
$17K |